News and resources

ATAGI statement on the use of Novavax COVID-19 vaccine

Novavax COVID-19 vaccine, also known as Nuvaxovid (Biocelect Pty Ltd/Novavax Inc) has been provisionally approved by the Therapeutic Goods Administration (TGA) for use in a primary course of vaccination in people aged 18 years and older.

Read more

New wellbeing app for Aboriginal and Torres Strait Islander communities

The Aboriginal and Islander Mental health initiative (AIMhi) Stay Strong app is a user-friendly digital tool developed by Menzies School of Health Research with Australian First Nations people.

Currently incorporated with Pitjantjatjara language and Aboriginal English the app supports service providers to have wellbeing conversations with First Nations people in primary care, specialist care and community settings, and may help facilitate discussions about family, friends, difficulties and plans.

Read more

Update on Pfizer supplies

Due to the high demand for vaccines over the holiday period, all Pfizer 12 years+ (Purple) orders arriving in the week ending 7 January 2022 or 14 January 2022 will include a one-off top-up of additional doses.

All primary care sites who have placed orders scheduled to arrive in the week ending 14 January 2022 will be provided an extra 240 doses of Pfizer (12 years+).

Read more